Gary Greenberg write in the New Yorker that “the psychiatric-drug industry is in trouble… In the past few years, one pharmaceutical giant after another—GlaxoSmithKline, AstraZeneca, Novartis, Pfizer, Merck, Sanofi—has shrunk or shuttered its neuroscience research facilities. Clinical trials have been halted, lines of research abandoned, and the new drug pipeline has been allowed to run dry.”
Presentation – Gary Greenberg from Mad in America on Vimeo.
